Significance of interleukin-17A in patients with nasal polyposis

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 2, 2011, Pages 169-175

  Shen, Yang ^a   Pan, Chang Kai ^a   Tang, Xin Ye ^a   Yang, Yu Cheng ^a   Ke, Xia ^a   Kou, Wei ^a   Wang, Xiao Qiang ^a   Hong, Su Ling ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Atopy; Eosinophil; Interleukin 17A; Nasal polyposis; Nonatopy

Indexed keywords

INTERLEUKIN 17;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL HYPERPLASIA; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; GENE EXPRESSION; GOBLET CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; PATHOGENESIS; PRICK TEST; SCORING SYSTEM; SYMPTOM; UPREGULATION;

ADULT; AGED; CELL MOVEMENT; DISEASE PROGRESSION; ENDOSCOPY; EOSINOPHILIA; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; PARANASAL SINUSES; RESPIRATORY HYPERSENSITIVITY; SKIN TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959371652     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Wynn R, Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope. 2004;114:811-813.
2. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis. establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:155-212.
3. Muñoz del Castillo F, Jurado-Ramos A, Fernández-Conde BL, Soler R, Barasona MJ, Cantillo E, et al. Allergenic profile of nasal polyposis. J Investig Allergol Clin Immunol. 2009;19:110-116.
4. Alobid I, Benítez P, Valero A, Berenguer J, Bernal-Sprekelsen M, Picado C,et al. The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis. Otolaryngol Head Neck Surg. 2006;134:609-612.
5. Staikuniene J, Vaitkus S, Japertiene LM, Ryskiene S. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas). 2008;44:257-265.
6. Bürger J, Macek M Jr, Stuhrmann M, Reis A, Krawczak M, Schmidtke J. Genetic influences in the formation of nasal polyps. Lancet. 1991; 337:974.
7. Molnar-Gabor E, Endreffy E, Rozsari A. HLA-DRB1, DQA1 and DQB1 genotypes in patients with nasal polyposis. Laryngoscope. 2000;110:422-425.
8. Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37:248-254.
9. Hussein MR, Fathi NA, El-Din AM, Hassan HI, Abdullah F, Al-Hakeem E, et al. Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res. 2008;14:321-328.
10. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006;7:135.
11. Ciprandi G, Fenoglio D, De Amici M, Quaglini S, Negrini S, Filaci G. Serum IL-17 levels in patients with allergic rhinitis. J Allergy Clin Immunol. 2008; 122(3):650-651.
12. Ciprandi G, De Amici M, Murdaca G, Fenoglio D, Ricciardolo F, Marseglia G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy. 2009;64:1375-1378.
13. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol. 2010;151:297-307.
14. Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4- induced activation of human keratinocytes. J Invest Dermatol. 2000;115:81-87.
15. Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;(20):1-136.
16. Lund VJ, Holmstrom M, Scadding GK. Functional endoscopic sinus surgery in the management of chronic rhinosinusitis. An objective assessment. J Laryngol Otol. 1991;105:832-835.
17. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117(3 Pt 2):35-40.
18. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117:S1-S7.
19. Gaffen SL. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep. 2009;11:365-370.
20. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, Uwambayinema F,et al. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol. 2010;184: 6367-6377. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G,
21. DeRuyck N, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122:961-968.
22. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, Wang DY, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124:478-484.
23. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL- 17A, IL-17F, and IL-23: implication for Th17 lymphocytesmediated allergic inflammation. J Immunol. 2008;180: 5625-5635.
24. Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17- dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med. 2009;180:720-730.
25. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med. 2008;178:1023-1032.
26. Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, et al. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol. 2010;151:8-16.
27. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-1289.
28. Robinson S, Douglas R, Wormald PJ. The relationship between atopy and chronic rhinosinusitis. Am J Rhinol. 2006;20:625-628.
29. Scavuzzo MC, Fattori B, Ruffoli R, Rocchi V, Carpi A, Berni R, et al. Inflammatory mediators and eosinophilia in atopic and nonatopic patients with nasal polyposis. Biomed Pharmacother. 2005; 59:323-329.
30. Alatas N, Baba F, San I, Kurcer Z. Nasal polyp diseases in allergic and nonallergic patients and steroid therapy. Otolaryngol Head Neck Surg. 2006; 135:236-242.
31. Cheng W, Zheng C, Tian J, Shi G. T helper cell population and eosinophilia in nasal polyps. J Investig Allergol Clin Immunol. 2007;17:297-301.
32. Van Bruaene N, Pérez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008; 121:1435-41, 1441.e1-3.
33. Shi J, Fan Y, Xu R, Zuo K, Cheng L, Xu G, et al. Characterizing Tcell phenotypes in nasal polyposis in Chinese patients. J Investig Allergol Clin Immunol. 2009;19:276-282.